ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.65B
Enterprise Value 33.25B
Trailing P/E N/A
Forward P/E 1-21.84
PEG Ratio (5 yr expected) 1-0.38
Price/Sales (ttm)15.36
Price/Book (mrq)8.73
Enterprise Value/Revenue 313.66
Enterprise Value/EBITDA 6-11.72

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -116.10%
Operating Margin (ttm)-117.81%

Management Effectiveness

Return on Assets (ttm)-41.11%
Return on Equity (ttm)-76.45%

Income Statement

Revenue (ttm)237.9M
Revenue Per Share (ttm)1.81
Quarterly Revenue Growth (yoy)28.80%
Gross Profit (ttm)18.31M
EBITDA -277.23M
Net Income Avi to Common (ttm)-276.2M
Diluted EPS (ttm)-2.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)414.32M
Total Cash Per Share (mrq)2.87
Total Debt (mrq)11.22M
Total Debt/Equity (mrq)2.68
Current Ratio (mrq)6.35
Book Value Per Share (mrq)2.90

Cash Flow Statement

Operating Cash Flow (ttm)-186.41M
Levered Free Cash Flow (ttm)-89.35M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.34
52-Week Change 342.11%
S&P500 52-Week Change 34.96%
52 Week High 328.67
52 Week Low 312.77
50-Day Moving Average 325.41
200-Day Moving Average 322.49

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 3863.08k
Shares Outstanding 5144.17M
Float 104.36M
% Held by Insiders 10.30%
% Held by Institutions 198.72%
Shares Short (Apr 30, 2019) 411.18M
Short Ratio (Apr 30, 2019) 49.01
Short % of Float (Apr 30, 2019) 413.52%
Short % of Shares Outstanding (Apr 30, 2019) 47.75%
Shares Short (prior month Mar 29, 2019) 410.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A